News

Mast is a responsible company that believes in taking a proportionate view on the likelihood of a number of events that may be outside of its control.

During ‘World Antimicrobial Awareness Week’ Mast unite to preserve antimicrobials by continuing to support Antibiotic stewardship, in providing and continually updating its range of in vitro diagnostic (IVD) Antimicrobial Resistance (AMR) products to reduce time to appropriate treatment decision and allow for a more targeted use of therapy against infection.

Mast are pleased to announce the launch of the new ESPLINE^® SARS-CoV-2 for the detection of COVID-19.

Our opening hours for this holiday season

MAST is pleased to announce that it has been awarded the Public Health England (PHE) tender for the exclusive supply of Treponema pallidum particle agglutination assays (TPPA).

Mast is pleased to announce it has been awarded the Public Health England (PHE) tender for the exclusive supply of antibiotic susceptibility (AST) and AMR discs.

MAST^®ALEX-MRSA (RST501); for the detection of penicillin binding protein 2’ (PBP2’) and confirmation of Methicillin resistant Staphylococcus aureus (MRSA)

CRYOBANK^® is based on a cryovial system comprising chemically treated beads immersed in a special cryogenic preserving solution.

COVID-19 Update

Mast is pleased to announce the launch of NEW additions to the MASTDISCS^® AST range for EUCAST and CLSI methodology: